PKBO

Peak Bio, Inc. Common Stock
PKBO

Overview Fund Activity
Delisted

PKBO was delisted on the 9th of January, 2023.

Back to rankings

30 hedge funds and large institutions have $33.4M invested in Peak Bio, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+6
Holders Change %
+25%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DM
Deerfield Management
New York
+$7.1M
2
WRBC
W.R. Berkley Corp
Connecticut
+$1.96M
3
KPF
K2 Principal Fund
Ontario, Canada
+$669K
4
DKCM
Davidson Kempner Capital Management
New York
+$479K
5
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$392K

Top Sellers

1
MP
Mangrove Partners
Connecticut
-$1.23M
2
KIM
Karpus Investment Management
New York
-$96K
3
Citadel Advisors
Citadel Advisors
Florida
-$36.5K
4
PAM
Panagora Asset Management
Massachusetts
-$18K
Name Holding Trade Value Shares
Change 		Shares
Change %
CM
26
Crestline Management
Texas
$205K – – –
RCM
27
Rivernorth Capital Management
Florida
$196K +$196K +20,000 New
RA
28
RiverPark Advisors
New York
$133K – – –
UBS Group
29
UBS Group
Switzerland
$15K +$15K +1,500 New
TRCT
30
Tower Research Capital (TRC)
New York
$1K – – –
MP
31
Mangrove Partners
Connecticut
– -$1.23M -126,844 Closed
PAM
32
Panagora Asset Management
Massachusetts
– -$18K -1,810 Closed
1
2